We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Abbott Laboratories | NYSE:ABT | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.4991 | -0.47% | 105.4009 | 106.47 | 105.14 | 106.47 | 2,065,598 | 20:21:43 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
WHITE MILES D |
2. Issuer Name
and
Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__ X __ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) Chairman and CEO |
100 ABBOTT PARK ROAD |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
ABBOTT PARK, IL 60064-6400 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common shares without par value | 7/25/2016 | M | 550000 | A | $25.2461 | 2010517 | D | |||
Common shares without par value | 7/25/2016 | P | 3647 | A | $43.155 | 2014164 | D | |||
Common shares without par value | 7/25/2016 | P | 13500 | A | $43.29 | 2027664 | D | |||
Common shares without par value | 7/25/2016 | P | 20602 | A | $43.22 | 2048266 | D | |||
Common shares without par value | 7/25/2016 | P | 7300 | A | $43.14 | 2055566 | D | |||
Common shares without par value | 7/25/2016 | P | 300 | A | $43.065 | 2055866 | D | |||
Common shares without par value | 7/25/2016 | P | 3800 | A | $43.24 | 2059666 | D | |||
Common shares without par value | 7/25/2016 | P | 35664 | A | $43.08 | 2095330 | D | |||
Common shares without par value | 7/25/2016 | P | 12600 | A | $43.19 | 2107930 | D | |||
Common shares without par value | 7/25/2016 | P | 3220 | A | $43.145 | 2111150 | D | |||
Common shares without par value | 7/25/2016 | P | 1800 | A | $43.185 | 2112950 | D | |||
Common shares without par value | 7/25/2016 | P | 2100 | A | $43.16 | 2115050 | D | |||
Common shares without par value | 7/25/2016 | P | 8700 | A | $43.15 | 2123750 | D | |||
Common shares without par value | 7/25/2016 | P | 100 | A | $43.32 | 2123850 | D | |||
Common shares without par value | 7/25/2016 | P | 1900 | A | $43.115 | 2125750 | D | |||
Common shares without par value | 7/25/2016 | P | 7080 | A | $43.18 | 2132830 | D | |||
Common shares without par value | 7/25/2016 | P | 3504 | A | $43.225 | 2136334 | D | |||
Common shares without par value | 7/25/2016 | P | 100 | A | $43.1525 | 2136434 | D | |||
Common shares without par value | 7/25/2016 | P | 9100 | A | $43.235 | 2145534 | D | |||
Common shares without par value | 7/25/2016 | P | 9198 | A | $43.265 | 2154732 | D | |||
Common shares without par value | 7/25/2016 | P | 6758 | A | $43.25 | 2161490 | D | |||
Common shares without par value | 7/25/2016 | P | 100 | A | $43.2725 | 2161590 | D | |||
Common shares without par value | 7/25/2016 | P | 200 | A | $43.335 | 2161790 | D | |||
Common shares without par value | 7/25/2016 | P | 10300 | A | $43.07 | 2172090 | D | |||
Common shares without par value | 7/25/2016 | P | 25400 | A | $43.09 | 2197490 | D | |||
Common shares without par value | 7/25/2016 | P | 6575 | A | $43.245 | 2204065 | D | |||
Common shares without par value | 7/25/2016 | P | 14802 | A | $43.26 | 2218867 | D | |||
Common shares without par value | 7/25/2016 | P | 23598 | A | $43.275 | 2242465 | D | |||
Common shares without par value | 7/25/2016 | P | 10499 | A | $43.105 | 2252964 | D | |||
Common shares without par value | 7/25/2016 | P | 100 | A | $43.1725 | 2253064 | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Option (right to buy) (1) | $25.2461 | 7/25/2016 | M | 550000 | 2/16/2010 | 2/15/2017 | Common shares | 550000 | $25.2461 | 0 | D |
Explanation of Responses: | |
( 1) | Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
Remarks:
Form 1 of 5. The transactions reported on this Form 4 are part of a series of transactions pursuant to which Mr. White personally invested $45.5 million in cash to purchase a total of 1,281,500 shares on his own account, increasing his total ownership from 1,460,517 shares to 2,742,017 shares. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
WHITE MILES D
100 ABBOTT PARK ROAD ABBOTT PARK, IL 60064-6400 |
X |
|
Chairman and CEO |
|
Signatures
|
||
John A. Berry, by power of attorney for Miles D. White | 7/27/2016 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Abbott Laboratories Chart |
1 Month Abbott Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions